Related Experiment Videos
Exploratory Preoperative Risk Stratification of Uterine Mesenchymal Tumors in Postmenopausal Women with Complementary
Xiaojie Wan1, Tao Zhang1, Jingyi Li1
1Department of Obstetrics and Gynecology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Diagnostics (Basel, Switzerland)
|August 13, 2026
Summary
A new model using preoperative data shows promise in distinguishing uterine mesenchymal tumors from fibroids in postmenopausal women. Further validation is needed for clinical use.
Area of Science:
- Gynecologic Oncology
- Pathology
- Genomics
Background:
- Differentiating uterine mesenchymal tumors from fibroids preoperatively is difficult in postmenopausal women.
- Uterine mesenchymal tumors require distinct management strategies compared to benign fibroids.
Purpose of the Study:
- To develop an exploratory risk-stratification model for uterine mesenchymal tumors.
- To characterize molecular differences between uterine leiomyosarcoma and fibroids.
Main Methods:
- Retrospective case-control study of postmenopausal women with uterine masses (23 tumors, 92 fibroids).
- Logistic regression analysis for risk model development and validation (ROC, calibration, decision curve analysis).
- Transcriptomic analysis of GEO dataset GSE64763 for molecular profiling.
Main Results:
- Pelvic pressure, abnormal uterine bleeding, and tumor diameter were significant predictors of mesenchymal tumors.
- The risk model demonstrated good performance with an AUC of 0.859.
- Transcriptomic analysis revealed distinct gene expression patterns and cell cycle pathway enrichment in leiomyosarcoma.
Conclusions:
- An exploratory preoperative risk model shows preliminary ability to differentiate uterine mesenchymal tumors.
- Further external validation in prospective cohorts is essential to determine clinical utility.